Barry M. Markaverich

2.6k total citations
66 papers, 2.2k citations indexed

About

Barry M. Markaverich is a scholar working on Genetics, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Barry M. Markaverich has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Genetics, 27 papers in Molecular Biology and 12 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Barry M. Markaverich's work include Estrogen and related hormone effects (58 papers), Effects and risks of endocrine disrupting chemicals (12 papers) and DNA and Nucleic Acid Chemistry (9 papers). Barry M. Markaverich is often cited by papers focused on Estrogen and related hormone effects (58 papers), Effects and risks of endocrine disrupting chemicals (12 papers) and DNA and Nucleic Acid Chemistry (9 papers). Barry M. Markaverich collaborates with scholars based in United States, Sweden and Australia. Barry M. Markaverich's co-authors include James H. Clark, Mary Ann Alejandro, Susan Upchurch, Rebecca Roberts, Kevin Shoulars, Brian S. Middleditch, Gregory A. Johnson, James W. Hardin, Charles L. Densmore and Shaila K. Mani and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Barry M. Markaverich

66 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry M. Markaverich United States 28 1.1k 894 283 281 273 66 2.2k
Günter Vollmer Germany 28 881 0.8× 915 1.0× 680 2.4× 355 1.3× 244 0.9× 127 2.5k
Yukitomo Arao United States 21 672 0.6× 780 0.9× 140 0.5× 155 0.6× 304 1.1× 55 1.8k
Jean‐François Savouret France 27 325 0.3× 779 0.9× 177 0.6× 109 0.4× 344 1.3× 41 2.1k
Jay Wimalasena United States 30 1.0k 0.9× 1.7k 1.9× 314 1.1× 201 0.7× 127 0.5× 59 3.4k
Deodutta Roy United States 27 913 0.8× 1.5k 1.6× 129 0.5× 142 0.5× 418 1.5× 88 2.8k
Peter H. Jellinck Canada 23 705 0.6× 647 0.7× 97 0.3× 395 1.4× 286 1.0× 116 1.8k
Adele Vivacqua Italy 31 1.7k 1.5× 1.6k 1.8× 239 0.8× 434 1.5× 232 0.8× 56 3.3k
R. Knüppen Germany 30 1.6k 1.4× 885 1.0× 206 0.7× 722 2.6× 269 1.0× 170 3.0k
A. Trentalance Italy 23 731 0.6× 826 0.9× 126 0.4× 258 0.9× 62 0.2× 72 1.9k
Clifford W. Welsch United States 26 748 0.7× 778 0.9× 175 0.6× 387 1.4× 138 0.5× 61 2.4k

Countries citing papers authored by Barry M. Markaverich

Since Specialization
Citations

This map shows the geographic impact of Barry M. Markaverich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry M. Markaverich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry M. Markaverich more than expected).

Fields of papers citing papers by Barry M. Markaverich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry M. Markaverich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry M. Markaverich. The network helps show where Barry M. Markaverich may publish in the future.

Co-authorship network of co-authors of Barry M. Markaverich

This figure shows the co-authorship network connecting the top 25 collaborators of Barry M. Markaverich. A scholar is included among the top collaborators of Barry M. Markaverich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry M. Markaverich. Barry M. Markaverich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markaverich, Barry M., et al.. (2012). Multiple Sites of Type II Site Ligand (Luteolin and BMHPC) Regulation of Gene Expression in PC-3 Cells. International Journal of Biomedical Science. 8(4). 219–232. 9 indexed citations
2.
Markaverich, Barry M., et al.. (2010). Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 122(4). 219–231. 31 indexed citations
3.
Markaverich, Barry M., et al.. (2007). Tetrahydrofurandiol Stimulation of Phospholipase A 2 , Lipoxygenase, and Cyclooxygenase Gene Expression and MCF-7 Human Breast Cancer Cell Proliferation. Environmental Health Perspectives. 115(12). 1727–1731. 13 indexed citations
4.
Markaverich, Barry M., Mary Ann Alejandro, Shaila K. Mani, et al.. (2007). Tetrahydrofurandiols (THF-diols), Leukotoxindiols (LTX-diols), and Endocrine Disruption in Rats. Environmental Health Perspectives. 115(5). 702–708. 30 indexed citations
5.
Shoulars, Kevin, et al.. (2006). Reconstitution of the type II [3H]estradiol binding site with recombinant histone H4. The Journal of Steroid Biochemistry and Molecular Biology. 99(1). 1–8. 7 indexed citations
6.
7.
Mani, Shaila K., Andrea Reyna, Mary Ann Alejandro, John Crowley, & Barry M. Markaverich. (2005). Disruption of male sexual behavior in rats by tetrahydrofurandiols (THF-diols). Steroids. 70(11). 750–754. 43 indexed citations
8.
Markaverich, Barry M., Jan R. Crowley, Mary Ann Alejandro, et al.. (2005). Leukotoxin Diols from Ground Corncob Bedding Disrupt Estrous Cyclicity in Rats and Stimulate MCF-7 Breast Cancer Cell Proliferation. Environmental Health Perspectives. 113(12). 1698–1704. 39 indexed citations
9.
Markaverich, Barry M., Mary Ann Alejandro, Lois A. Zitzow, et al.. (2002). Identification of an Endocrine Disrupting Agent from Corn with Mitogenic Activity. Biochemical and Biophysical Research Communications. 291(3). 692–700. 42 indexed citations
10.
Markaverich, Barry M., et al.. (2002). A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells.. Environmental Health Perspectives. 110(2). 169–177. 59 indexed citations
11.
Markaverich, Barry M., et al.. (2001). Purification and characterization of nuclear type II [3H]estradiol binding sites from the rat uterus. Steroids. 66(9). 707–719. 14 indexed citations
12.
Markaverich, Barry M., et al.. (1997). Partial purification and characterization of methyl-p-hydroxyphenyllactate esterase in rat uterine cytosol. Steroids. 62(3). 321–330. 6 indexed citations
13.
14.
Densmore, Charles L., et al.. (1994). Chromatographic resolution of the type II estrogen binding site and a tyrosinase-like enzymatic activity from rat uterine nuclei. Steroids. 59(4). 282–287. 7 indexed citations
15.
Densmore, Charles L., Barry M. Markaverich, Bert W. O’Malley, & J.H. Clark. (1989). Characterization and partial purification of an estrogen type II binding site in chick oviduct cytosol. Biochemistry. 28(19). 7788–7796. 15 indexed citations
16.
Markaverich, Barry M., et al.. (1989). Intracellular [3H]dopamine binding sites in normal and malignant cells: Relationships to cell proliferation. Biochemical and Biophysical Research Communications. 165(1). 391–400. 10 indexed citations
17.
Markaverich, Barry M., Rebecca Roberts, Mary Ann Alejandro, et al.. (1988). Bioflavonoid interaction with rat uterine type ii binding sites and cell growth inhibition. Journal of Steroid Biochemistry. 30(1-6). 71–78. 177 indexed citations
18.
Markaverich, Barry M., Rebecca Roberts, Mary Ann Alejandro, & James H. Clark. (1984). An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.. PubMed. 44(4). 1515–9. 43 indexed citations
19.
Markaverich, Barry M. & James H. Clark. (1981). Quantitation of nuclear-estrogen receptors in the rat uterus by [3H]-estradiol exchange. Journal of Steroid Biochemistry. 15. 289–292. 4 indexed citations
20.
Clark, James H., Barry M. Markaverich, Susan Upchurch, Håkan Eriksson, & James W. Hardin. (1979). Nuclear Binding of the Estrogen Receptor: Heterogeneity of Sites and Uterotropic Response. Advances in experimental medicine and biology. 117. 17–46. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Günter Vollmer Breakdown of academic impact, for papers by Yukitomo Arao Breakdown of academic impact, for papers by Jean‐François Savouret Breakdown of academic impact, for papers by Jay Wimalasena Breakdown of academic impact, for papers by Deodutta Roy Breakdown of academic impact, for papers by Peter H. Jellinck Breakdown of academic impact, for papers by Adele Vivacqua Breakdown of academic impact, for papers by R. Knüppen Breakdown of academic impact, for papers by A. Trentalance Breakdown of academic impact, for papers by Clifford W. Welsch
Rankless by CCL
2026